8-K: Cohen & Co. Reports Q3 2026 Results, Dividend Declared
Current Report (8-K)
Cohen & Company Inc. announced third quarter 2026 financial results, reporting a significant decrease in investment banking revenue and adjusted pre-tax income, while also declaring a quarterly dividend of $0.25 per share.
Summary
- Cohen & Company Inc. reported third quarter 2026 financial results, with net income attributable to the company at $6.7 million ($0.12 per diluted share).
- Adjusted pre-tax income was $0.6 million ($0.10 per diluted share), a substantial decrease from the prior quarter and prior year quarter.
- Total revenues for the quarter were $32.4 million, down significantly from $69.5 million in the prior quarter and $84.2 million in the prior year quarter.
- Investment banking and new issue revenue saw a sharp decline to $12.7 million, impacted by over $17 million in mark-to-market losses.
- The company's gestation repo book reached an all-time high of $4.5 billion.
- The Board of Directors declared a quarterly dividend of $0.25 per share, payable on December 14, 2026.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a negative sentiment due to a significant drop in revenue and adjusted pre-tax income compared to prior periods, despite some positive operational highlights.
Positives
- The full-service boutique investment bank, Cohen & Company Capital Markets (CCM), underwrote six SPAC IPOs and one closed-end fund, raising $1.8 billion for clients.
- CCM advised on and raised capital for eight de-SPAC transactions, highlighting its strong position in SPAC advisory.
- The gestation repo book grew to an all-time high of $4.5 billion, demonstrating strength in the mortgage business.
- Enterprise net income was $6.9 million.
- Total equity increased by $14.9 million from December 31, 2025, to $117.5 million (excluding non-controlling interest) as of September 30, 2026.
- The company declared a quarterly dividend of $0.25 per share.
Negatives
- Total revenues decreased to $32.4 million from $69.5 million in the prior quarter and $84.2 million in the prior year quarter.
- Investment banking and new issue revenue dropped significantly to $12.7 million, down $41.3 million from the prior quarter and $55.9 million from the prior year quarter.
- Adjusted pre-tax income was $0.6 million, a sharp decline from $10.1 million in the prior quarter and $16.4 million in the prior year quarter.
- Net income attributable to Cohen & Company Inc. was $6.7 million ($0.12 per diluted share), down from $3.6 million ($0.94 per diluted share) in the prior quarter and $4.6 million ($2.58 per diluted share) in the prior year quarter.
- Mark-to-market adjustments in investment banking and new issue revenue resulted in over $17 million in losses during the quarter.
- Net trading revenue decreased to $12.5 million from $13.9 million in the prior quarter and $13.6 million in the prior year quarter.
Risks
- A decline in general economic conditions or the global financial markets, including those caused by inflation, rising interest rates, and the current geopolitical situation.
- Unfavorable market conditions may lead to a reduction in revenues from investment banking and new issue revenues, including from underwriting and placement activities.
- Losses caused by financial or other problems experienced by third parties.
- Losses due to unidentified or unanticipated risks.
- A lack of liquidity, i.e., ready access to funds for use in businesses.
- The ability to attract and retain personnel.
- Litigation and regulatory proceedings.
- Reputational harm due to losses or inability to sell securities purchased as an underwriter at anticipated price levels.
Future Outlook
The company is focused on consistent production through the end of the year and positioning itself for 2027 with a strong pipeline, believing in its future earnings potential and commitment to long-term stockholder value.
Management Comments
- "We are encouraged by the continued strong performance in our full-service boutique investment bank, Cohen & Company Capital Markets (CCM), and in our gestation repo business."
- "During the third quarter, CCM underwrote six SPAC IPOs and one closed-end fund, raising $1.8 billion for clients, and advised on and raised capital for eight de-SPAC transactions, exemplifying its status as a leading SPAC advisor on Wall Street."
- "Additionally, our gestation repo book grew to an all-time high of $4.5 billion during the quarter, illustrating the strength of our mortgage business."
- "While third quarter results were unfavorably impacted by more than $17 million of mark-to-market adjustments in our investment banking and new issue revenue line, in large part due to the environment in our businesses, we still generated $6.9 million of enterprise net income and $648,000 of adjusted pre-tax income."
- "We are focused on consistent production through the end of the year and positioning ourselves to enter 2027 with a strong pipeline."
- "We continue to believe in our future earnings potential and are committed to driving long-term value for our stockholders, including through our quarterly dividend."
- "We have generated $1.47 of fully diluted net income per share year to date and are confident in our future value creation potential."
Industry Context
StockSavvy.ai notes that the significant decline in investment banking and new issue revenue, attributed to mark-to-market adjustments and market environment, is a common challenge for financial services firms operating in volatile markets. The strength in the gestation repo business and SPAC advisory services highlights the company's diversified revenue streams and its ability to capitalize on specific market niches.
Comparison to Industry Standards
- The filing does not provide specific comparisons to industry standards or named competitors for the reported financial metrics.
- The company highlights its position as a 'leading SPAC advisor on Wall Street', suggesting a competitive standing in that specific market segment.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Daniel G. Cohen | November 12, 2026 | Appointed as Executive Chairman of the Board. |
Related Party Transactions
- Due from related parties: $1.371 million as of September 30, 2026.
- Due to related parties: $2.744 million as of September 30, 2026.
Stakeholder Impact
- Shareholders: Declaration of a $0.25 per share quarterly dividend provides a direct return. Management's commitment to long-term value creation is also a positive signal.
- Employees: Compensation is largely incentive-based and fluctuates with revenue, suggesting potential impact from revenue declines.
- Creditors: The company's debt levels and ability to service them are implicitly relevant, though no specific concerns are raised in this filing.
Next Steps
- Focus on consistent production through the end of 2026.
- Position the company to enter 2027 with a strong pipeline.
- Continue to evaluate the dividend policy each quarter.
- Continue to evaluate the valuation allowance against net operating loss and net capital loss tax assets.
Key Dates
| Date | Description |
|---|---|
| 2025-12-31 | December 31, 2025 balance sheet date. |
| 2026-06-30 | June 30, 2026 financial results for the prior quarter. |
| 2026-09-30 | September 30, 2026, end of the third quarter and balance sheet date. |
| 2026-11-12 | Date of the report and press release announcing Q3 2026 financial results. |
| 2026-11-30 | Record date for the quarterly dividend. |
| 2026-12-14 | Payment date for the quarterly dividend. |
Recommendation
holdThe significant decline in key financial metrics, particularly adjusted pre-tax income and investment banking revenue, warrants caution. While the company highlights strengths in specific areas like SPAC advisory and its repo business, and has declared a dividend, the overall financial performance trend is negative. A 'hold' recommendation reflects the uncertainty stemming from the revenue drop and the need to see sustained improvement and clarity on the impact of market conditions.
Keywords
Cohen & Company, Q3 2026, Financial Results, Investment Banking, SPAC, Gestation Repo, Dividend, Mark-to-market
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.